A New Berlin mother of four credits being awake during her kidney transplant surgery with helping get her life back.

Study published by Lancet Regional Health helps doctors manage new class of drugs for kidney transplant patients suffering organ rejectionSerial ...

PARIS, FRANCE, 22 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today it has completed the acquisition of Memo Therapeutics AG, a late-stage biotech company focused on p ...

The kidney is now the highest on the "wanted list" of organs, with 10,000 renal failure patients waiting for transplants.

Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically meaningful improvements of protein in urine observed as early as two weeks, with s ...

Highlights Dimerix acquires Phase 2-ready asset, DMX-652 - with potential for rapid advancement into a Phase 2 clinical study under an open US Investigational New ...

Dimerix Limited (ASX: DXB, "Dimerix") a clinical-stage biopharmaceutical company developing kidney disease treatments, is pleased to announce that it has acquired DMX-652 for all indications from ...

Each week, photographer Ruth Medjber asks one person to share a tale from their own life. This week, she meets kidney ...

Industry-wide coverage policy expands reimbursement framework for donor-derived cell-free DNA testing; Supports iMDx's commercial strategy in transplant monitoring; Final policy e ...

ROBINSON, Texas (KWTX) — Brandon Crouch was running out of time. The 54-year-old Robinson, Texas, man and owner of Ironhorse Roofing had been on dialysis for nearly three and a half years after Type 1 ...

Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically ...

Tormented by transience, Caitlin McDonald's life was as fragile and fleeting as the butterflies she saved from the street.